Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone in IBS-M/IBS-U
NCT02544152Phase 2Terminated
- Sponsor
- Sucampo
- Start
- Feb 2015
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cobiprostone in irritable bowel syndrome (IBS), sponsored by Sucampo. Started Feb 2015; status: terminated.
02
Drugs
cobiprostone
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02544152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02544152.